{"id":1078,"date":"2020-05-05T15:23:03","date_gmt":"2020-05-05T15:23:03","guid":{"rendered":"https:\/\/www.bioview.co.il\/denovo\/?post_type=news&#038;p=1078"},"modified":"2021-10-05T15:25:02","modified_gmt":"2021-10-05T15:25:02","slug":"introduction-of-the-innovative-mda-test-for-lung-cancer-early-diagnosis-a-session-jointly-organized-by-china-lung-cancer-prevention-alliance-and-zhuhai-sanmed-biotech-ltd","status":"publish","type":"news","link":"https:\/\/bioview.co.il\/denovo\/news\/introduction-of-the-innovative-mda-test-for-lung-cancer-early-diagnosis-a-session-jointly-organized-by-china-lung-cancer-prevention-alliance-and-zhuhai-sanmed-biotech-ltd\/","title":{"rendered":"Introduction of the innovative \u201cMDA TEST\u201d for lung cancer early diagnosis. A session jointly organized by China Lung Cancer Prevention Alliance and Zhuhai Sanmed Biotech Ltd."},"content":{"rendered":"\n<p>The MDA test is a lung nodule blood circulation abnormal cell detection technology, a clinical and practical early screening product for lung cancer. The technology uses fluorescence-labeled in situ hybridization to qualitatively detect the abnormal state of chromosomal mononuclear cells in human peripheral blood to perform auxiliary diagnosis of benign and malignant lung nodules.<\/p>\n\n\n\n<figure class=\"wp-block-embed-youtube wp-block-embed is-type-video is-provider-youtube wp-embed-aspect-4-3 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"MDA TEST Lung Cancer Early Diagnosis and Treatment\" width=\"640\" height=\"480\" src=\"https:\/\/www.youtube.com\/embed\/63LpLAGFbRs?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<p>Professor Bai Chunxue, Chairman of the China Lung Cancer Prevention Alliance, Director of the Shanghai Institute of&nbsp; &nbsp; Respiratory Diseases, and Director of the Institute of Respiratory&nbsp; Diseases of Fudan University<\/p>\n\n\n\n<p>Professor Ruth L. Katz, former Director of Cytopathology at the MD Anderson Cancer Center<\/p>\n\n\n\n<p>Professor Xu Tao, deputy Director of the ward of the Department of Respiratory and Critical Care Medicine from the Affiliated Hospital of Qingdao University<\/p>\n\n\n\n<p>Dr. Ye Xin, University of Illinois, USA, Zhuhai Sanmed Biotech Ltd. Director of Product Development &amp; Assistant General Manager<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-1078","news","type-news","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/bioview.co.il\/denovo\/wp-json\/wp\/v2\/news\/1078"}],"collection":[{"href":"https:\/\/bioview.co.il\/denovo\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/bioview.co.il\/denovo\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/bioview.co.il\/denovo\/wp-json\/wp\/v2\/media?parent=1078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}